Modular Medical Announces $4.4 Million Raised Through Warrant Exercise and Private Placement of New Warrants
Modular Medical Inc. $(MODD)$, a provider of innovative insulin delivery technology, has announced the exercise of certain warrants issued in May 2023 and March 2025, generating approximately $4.4 million in gross proceeds. In connection with the immediate cash exercise of 6,504,731 existing warrants at a reduced price of $0.68 per share, the company will issue new unregistered warrants to purchase up to 3,252,366 shares of common stock at an exercise price of $0.84 per share. These new warrants are exercisable immediately and have a five-year term. The proceeds will be used for working capital and general corporate purposes. Further details are available in the company's recent SEC filings.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1079139) on September 29, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。